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The demonstrated link between the emergence of H3N2 variant (H3N2v) influenza A viruses (IAVs) and swine exposure at agri-
cultural fairs has raised concerns about the human health risk posed by IAV-infected swine. Understanding the antigenic pro-
files of IAVs circulating in pigs at agricultural fairs is critical to developing effective prevention and control strategies. Here, 68
H3N2 IAV isolates recovered from pigs at Ohio fairs (2009 to 2011) were antigenically characterized. These isolates were com-
pared with other H3 IAVs recovered from commercial swine, wild birds, and canines, along with human seasonal and variant
H3N2 IAVs. Antigenic cartography demonstrated that H3N2 IAV isolates fromOhio fairs could be divided into two antigenic
groups: (i) the 2009 fair isolates and (ii) the 2010 and 2011 fair isolates. These same two antigenic clusters have also been ob-
served in commercial swine populations in recent years. HumanH3N2v isolates from 2010 and 2011 are antigenically clustered
with swine-origin IAVs from the same time period. The isolates recovered from pigs at fairs did not cross-react with ferret anti-
sera produced against the human seasonal H3N2 IAVs circulating during the past decade, raising the question of the degree of
immunity that the human population has to swine-origin H3N2 IAVs. Our results demonstrate that H3N2 IAVs infecting pigs at
fairs and H3N2v isolates were antigenically similar to the IAVs circulating in commercial swine, demonstrating that exhibition
swine can function as a bridge between commercial swine and the human population.
The swine-human interface at agricultural fairs has proven to bean important site for the bidirectional interspecies transmis-
sion of influenza A viruses (IAVs). Numerous cases of variant
influenza A have been linked to swine exposure at agricultural
fairs across the United States, and the first documented transmis-
sions of the 2009 pandemic (pdm09) H1N1 IAV from humans to
pigs also occurred at agricultural fairs (1–5). Since July 2011,more
than 325 confirmed human cases of H3N2 variant (H3N2v) influ-
enza A have occurred in 14 states (6).Many of these cases reported
direct or indirect contact with exhibited swine with limited sub-
sequent human-to-human transmission of H3N2v IAVs (7, 8).
Influenza A viruses can cause sporadic, epidemic, and pan-
demic respiratory disease in humans and from mild to severe re-
spiratory diseases in horses, pigs, domestic poultry, and sea mam-
mals (9–12). Because the tracheal epithelial cells of swine contain
both avian-like alpha-2,3-linked sialic acid receptors and human-
like alpha-2,6-linked sialic acid receptors (13, 14), pigs can be
infected by avian- and mammalian-origin IAVs, which may facil-
itate reassortment events and result in the subsequent generation
of novel IAVs capable of infecting humans (13, 14). Currently,
multiple antigenically and genetically divergent IAVs cocirculate
in swine populations, and antigenic recycling of IAVs can occur in
modern swine management systems where there is a continuous
supply of naive pigs (15). Antigenic characterization of the pdm09
(H1N1) IAV demonstrated that the H1 antigen had been circulat-
ing among swine for decades prior to the onset of the 2009 pan-
demic (16), confirming the potential for the emergence of pan-
demic IAV from pigs.
Influenza A virus was first isolated from swine in 1930 (17).
This H1N1 strain, likely derived from the 1918 H1N1 pandemic
IAV (18), was the only major IAV circulating among U.S. swine
for more than 60 years and is now known as “classical” swine
influenza virus. A triple reassortant H3N2 (trH3N2) IAV com-
posed of three genes (HA, NA, and PB1) derived from human
H3N2 seasonal influenza viruses (huH3N2), two genes (PB2 and
PA) from avian-origin IAVs, and three genes (NP, MP, and NS)
from classical swine influenza virus (19, 20) emerged in swine
populations in the mid-1990s and has since become well estab-
lished in North America. Phylogenetic analyses of HA genes from
H3N2 IAVs isolated from North American pigs after 1998 dem-
onstrate that these trH3N2 IAVs can be classified into at least four
genetic groups (clusters I, II, III, and IV) (21) with one lineage
(cluster IV) predominating since 2005. Neutralization assays with
swine antisera demonstrated that these four genetic clusters are
also antigenically distinct (22). Several reassortment events be-
tween trH3N2 IAVs, human-origin IAVs, and classical swine in-
fluenza virus have occurred since 1998, resulting in multiple gene
constellationswith variousHAandNAgenes in combinationwith
the triple reassortant internal gene (TRIG) cassette (which in-
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cludes PB2, PB1, PA,NP,NS, andMsegments) (23, 24). Viruses in
human cases of infection with swine-origin IAVs reported by the
Centers for Disease Control and Prevention (CDC) after 1998
were all characterized as containing the TRIG cassette and were
linked antigenically or genetically to IAVs concurrently circulat-
ing in pigs. Most of these cases were isolated infections in which
patients reported indirect or direct exposure to pigs (25, 26).
The degree of immunity that the human population has to
swine-origin H3N2 IAVs is open to question (6). Because agricul-
tural fairs bring people into close contact with swine, defining the
antigenic profiles of the IAVs circulating in exhibited pigs at fairs
is critical to developing effective strategies to prevent and/or con-
trol human infections by swine-origin IAVs. Hemagglutination
inhibition (HI) tests were used to compare the antigenic profiles
of IAV isolates recovered from pigs at Ohio agricultural fairs dur-
ing 2009 to 2011 with those of H3 IAV isolates of human, swine,
canine, and avian origins. The antigenic profiles from HI tests
were validated by microneutralization (MN) assays. The genomic
sequences of the HA and NA segments of selected swine-origin
H3N2 IAV isolates were also analyzed to investigate the genomic
changes contributing to antigenic profiles.
MATERIALS AND METHODS
Viruses and sera. From 2009 to 2011, a systematically designed surveil-
lance effort was performed across 53 agricultural fairs in Ohio (27). From
the 1,073 pigs sampled, 155 were positive for IAV, with 128 H3N2 viruses
being isolated. Sixty-eight representative (from the 128 total) H3N2 IAVs
(Table 1) were selected for the present study. TheHA,NA, andM genes of
these isolates were characterized as described previously (27). Addition-
ally, four H3N2v IAV isolates (Table 1) were kindly provided by CDC,
Atlanta, GA. Also included in the study, and listed in Tables 2 and 3, were
12H3N2 IAV isolates from commercial pigs, twoH3N2 IAV isolates from
wild birds, twoH3 IAV isolates fromdogs (28, 29), and 12human seasonal
H3N2 isolates. After being propagated in Madin-Darby canine kidney
(MDCK) cells (ATCC, Manassas, VA, USA), all IAVs were aliquoted and
stored at70°C until use.
Ferret antisera were generated in 6- to 8-week-old ferrets, which had
baseline HI titers of less than 1:10 against A/Brisbane/10/2007 (H3N2),
A/Brisbane/59/2007 (H1N1), and A/California/4/2009 (H1N1). Each fer-
ret was inoculated intranasally with 106 50% tissue culture infective doses
(TCID50) for each IAV isolate (Table 1). Sera were collected from the
ferrets at 3weeks postinoculation if theHI titer in a ferret was at least 1:160
at 2 weeks postinoculation. Otherwise, a second dose of 106 TCID50 of the
corresponding virus was given and serum was collected 5 weeks after the
first inoculation. All sera were aliquoted and stored at70°C until use.
Eight swine H3N2 IAV isolates representing six fair events were used
to generate ferret antisera. The virus designation is summarized in Table
4. In addition, ferret antisera were produced against 12 human seasonal
H3N2 IAV isolates, two H3N2 IAV isolates from wild birds, and two
canine H3 IAV isolates for comparison. All these isolates are contempo-
rary H3 IAVs (Tables 1, 2, and 3).
Genomic sequencing. Viral RNA was extracted using the RNeasy
minikit according to themanufacturer’s instructions (Qiagen Inc., Valen-
cia, CA, USA). Reverse transcription and PCR were performed using in-
fluenza virus-specific primers (30). PCR products were separated using
agarose gel electrophoresis and purified using theQIAquick gel extraction
kit (Qiagen Inc., Valencia, CA, USA). Sequencing was performed by the
Life Sciences Core Laboratories Center at Cornell University using the
Applied Biosystems automated 3730 DNA analyzer, with BigDye Termi-
nator chemistry and AmpliTaq-FS DNA polymerase. The HA genes of
nine agricultural fair isolates are fully sequenced, and the HA genes of 12
commercial swine IAV isolates were partially sequenced and at least cov-
ered the entire HA1.
Hemagglutination inhibition assay. Before conducting HI tests, fer-
ret antisera were treated with receptor-destroying enzyme (RDE) (Denka
Seiken Co., Tokyo, Japan) at 37°C for 18 h and then heat inactivated at
55°C for 30 min. The sera were then diluted with phosphate-buffered
saline (for a final dilution of 1:10) and tested byHI assay with 0.5% turkey
red blood cells according to the WHOmanual on animal influenza diag-
nosis and surveillance (http://www.who.int/vaccine_research/diseases
/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5
.pdf).
Microneutralization assay. The sera were tested by performing a mi-
croneutralization (MN) assay in MDCK cells. Neutralizing titers were
expressed as the reciprocal of the serum dilution that inhibited 50% of
viral growth of 100 tissue culture infective doses (TCID50) of virus. The
MN titers were determined by HA assay using 0.5% turkey red blood cells
(31).
Antigenic cartography and antigenic cluster identification. Anti-
genic cartography was generated based onHI data using AntigenMap (32,
33) by setting 1:10 as the low reactor. Data normalization was performed
as previously reported (34–36). Influenza A viruses were classified into
antigenic clusters using k-mean clustering (37). Student’s t test was per-
formed to assess the significance of antigenic distances.
Molecular characterization and phylogenic analysis. The multiple
sequence alignments were conducted by using the MUSCLE software
package (38). The phylogenetic analyses were performed usingmaximum
likelihood by the GARLI version (39), and bootstrap resampling analyses
were conducted using PAUP* 4.0 Beta (40) with a neighborhood joining
method, as previously described (41).
Nucleotide sequence accession numbers. The GenBank accession
numbers of the sequenced HA genes are CY130717, CY130719,
CY131957, CY131959, CY131053, CY131055, CY130909, CY130911, and
KF007981 to KF008000.
RESULTS
Genetic characterization of H3N2 influenza A viruses. Phyloge-
netic analysis of HA genes showed that the HA genes of four hu-
manH3N2v isolates and all H3N2 IAV isolates from both agricul-
tural fairs and commercial swine farms belonged to cluster IV
(Fig. 1A) (22). A high degree of genetic diversity was observed
among the viruses. The amino acid sequence identity between
the HA amino acid sequence of A/swine/Ohio/10SW130/2010
(H3N2) and that of A/swine/Ohio/11SW111/2011 (H3N2)
was 99.3%; the HA protein sequence identity between A/swine/
Ohio/09SW64/2009 (H3N2) and A/swine/Ohio/10SW130/2010
(H3N2) and that between A/swine/Ohio/09SW64/2009 (H3N2)
and A/swine/Ohio/11SW111/2011 (H3N2) were 95.8% and
95.1%, respectively, and the human H3N2v isolate A/Iowa/07/
2011 (H3N2) was 99.5% identical to A/swine/Ohio/11SW111/
2011 (H3N2) (Table 5).
The phylogenetic trees of influenza virusNAgenes showed that
the NA genes of these agricultural fair isolates were phylogeneti-
cally close to the NA gene of A/swine/Ontario/33853/2005 and to
those NA genes of other IAVs in the same cluster, similar to the
case with the HA genes (Fig. 1B).
Antigenic diversity of H3N2 IAVs from pigs at agricultural
fairs. The antisera generated against selected IAV isolates from
pigs at Ohio fairs during 2010 and 2011 cross-reacted with the
isolates from 2010 and 2011 fairs but were less reactive to IAVs
recovered from pigs at fairs during 2009. Similarly, the antisera
generated against IAV isolates from the 2009 fair season reacted
poorly with 2010 and 2011 swine isolates (Table 1). The IAV iso-
lates from pigs at agricultural fairs could be divided into two an-
tigenic groups: (i) the 2009 fair isolates (antigenic cluster H3N2
Feng et al.
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TABLE 1 Antigenic characterization of H3N2 swine influenza viruses from Ohio agricultural fairs, 2009 to 2011, using hemagglutination inhibition
assay against ferret antisera for H3N2 swine influenza viruses
Virusa
Antigenic
groupb
Titer for ferret antiserumc:
09SW64 09SW96 10SW130 10SW156 10SW215 11SW111 11SW208 11SW347
09SW64 Alpha 1,600 640 20 20 40 10 10 10
09SW96 Alpha 1,280 960 20 10 40 10 10 10
10SW130 Beta 20 10 640 640 640 640 640 320
10SW156 Beta 20 10 320 1,040 640 640 640 640
10SW215 Beta 80 20 1,280 1,280 960 640 640 640
11SW111 Beta 20 10 40 80 40 1,040 640 320
11SW208 Beta 20 10 320 320 640 640 1,024 640
11SW347 Beta 20 10 80 320 320 640 1,280 576
SI/60/89 10 10 20 10 10 10 10 10
AN/03/93 10 10 20 10 10 10 10 10
JO/33/94 10 10 10 10 10 10 10 10
NA/933/95 10 10 10 20 10 10 10 10
SY/05/97 10 10 10 10 10 10 10 10
WI/67/05 10 10 10 10 10 10 10 10
CIVH3N2 10 10 10 10 10 10 10 10
CIVH3N8 10 10 10 10 10 10 10 10
99AIVH3N2 10 10 10 10 10 10 10 10
11AIVH3N2 10 10 10 10 10 10 10 10
Isolates from exhibition swine
A/swine/Ohio/09SW63/2009 Alpha 2,560 1,280 80 80 80 320 80 40
A/swine/Ohio/09SW65/2009 Alpha 1,280 640 40 20 40 160 40 20
A/swine/Ohio/09SW66/2009 Alpha 2,560 1,280 160 80 160 640 80 40
A/swine/Ohio/09SW69/2009 Alpha 1,280 640 40 10 80 320 40 40
A/swine/Ohio/09SW73/2009 Alpha 2,560 1,280 160 80 80 640 80 40
A/swine/Ohio/09SW74/2009 Alpha 2,560 1,280 80 40 80 320 80 40
A/swine/Ohio/09SW77/2009 Alpha 2,560 2,560 160 160 160 320 160 80
A/swine/Ohio/09SW79/2009 Alpha 2,560 1,280 80 80 160 320 80 40
A/swine/Ohio/09SW80/2009 Alpha 2,560 640 40 40 80 320 80 40
A/swine/Ohio/09SW81/2009 Alpha 1,280 640 80 40 80 160 40 40
A/swine/Ohio/09SW82/2009 Alpha 1,280 640 40 20 40 160 40 20
A/swine/Ohio/09SW83/2009 Alpha 1,280 320 40 40 80 160 80 20
A/swine/Ohio/09SW84/2009 Alpha 1,280 640 40 40 80 320 40 20
A/swine/Ohio/09SW85/2009 Alpha 1,280 640 40 40 80 320 40 20
A/swine/Ohio/09SW87/2009 Alpha 2,560 640 40 40 80 320 40 20
A/swine/Ohio/09SW88/2009 Alpha 1,280 640 40 20 40 160 40 20
A/swine/Ohio/09SW89/2009 Alpha 1,280 640 80 40 80 320 160 40
A/swine/Ohio/09SW90/2009 Alpha 1,280 640 40 40 80 160 40 20
A/swine/Ohio/09SW91/2009 Alpha 1,280 640 40 40 80 160 40 20
A/swine/Ohio/09SW92/2009 Alpha 2,560 640 80 40 80 320 80 40
A/swine/Ohio/09SW93/2009 Alpha 1,280 640 80 40 80 160 40 40
A/swine/Ohio/09SW94/2009 Alpha 1,280 640 40 20 80 320 40 20
A/swine/Ohio/09SW97/2009 Alpha 640 320 20 20 20 80 20 10
A/swine/Ohio/09SW98/2009 Alpha 1,280 1,280 20 20 80 160 40 40
A/swine/Ohio/10SW121/2010 Beta 80 10 640 640 1,280 640 640 640
A/swine/Ohio/10SW122/2010 Beta 160 10 1,280 1,280 1,280 2,560 1,280 1,280
A/swine/Ohio/10SW125/2010 Beta 160 20 1,280 1,280 1,280 1,280 1,280 1,280
A/swine/Ohio/10SW127/2010 Beta 40 10 320 640 640 640 640 320
A/swine/Ohio/10SW128/2010 Beta 40 10 320 640 640 640 640 320
A/swine/Ohio/10SW131/2010 Beta 320 20 1,280 1,280 2,560 1,280 1,280 1,280
A/swine/Ohio/10SW132/2010 Beta 160 10 1,280 1,280 2,560 1,280 1,280 1,280
A/swine/Ohio/10SW133/2010 Beta 40 10 640 640 640 640 640 320
A/swine/Ohio/10SW134/2010 Beta 40 10 640 640 640 640 640 320
A/swine/Ohio/10SW135/2010 Beta 320 20 2,560 2,560 2,560 2,560 2,560 1,280
A/swine/Ohio/10SW136/2010 Beta 40 10 640 640 1,280 640 640 640
A/swine/Ohio/10SW137/2010 Beta 320 10 1,280 1,280 1,280 1,280 1,280 1,280
A/swine/Ohio/10SW139/2010 Beta 160 10 1,280 1,280 1,280 1,280 1,280 1,280
A/swine/Ohio/10SW202/2010 Beta 80 10 640 640 640 640 640 640
(Continued on following page)
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alpha) and (ii) the 2010 and 2011 fair isolates (antigenic cluster
H3N2 beta).
The k-mean clustering also grouped 84 isolates (68 exhibition
swine isolates, 4 humanH3N2v isolates, and 12 commercial swine
isolates) into one of the two identified antigenic clusters (35 in
cluster alpha and 49 in cluster beta) as summarized in Table 1. The
average distance between the viruseswithin cluster alpha and clus-
ter beta was 1.45 and 1.07 units, respectively. The minimum
distance between antigenic clusters was 2.32 units (e.g., A/Penn-
sylvania/14/2010 and A/swine/Iowa/11333/2006), and the maxi-
mum distance between clusters was 6.53 units (e.g., A/swine/
North Carolina/23592/2009 and A/swine/Ohio/11SW214/2011).
The average distance between two clusters from their centers was
4.18 units. Each unit corresponds to a 2-fold change in HI assay.
Statistically, the antigenic distances between clusters were signifi-
cantly different from those within each antigenic cluster (P 
0.001). Additionally, there was no significant difference among
the antigenic profiles for isolates from fairs collected in the same
year, which belong to the same antigenic cluster. Thus, it seems
that dynamics of antigenic changes of IAVs in pigs at Ohio’s agri-
cultural fairs were not dependent on the locations or the years of
fairs.
TABLE 1 (Continued)
Virusa
Antigenic
groupb
Titer for ferret antiserumc:
09SW64 09SW96 10SW130 10SW156 10SW215 11SW111 11SW208 11SW347
A/swine/Ohio/10SW203/2010 Beta 80 10 1,280 1,280 1,280 1,280 640 640
A/swine/Ohio/10SW204/2010 Beta 80 10 640 1,280 1,280 1,280 1,280 640
A/swine/Ohio/10SW205/2010 Beta 40 10 640 640 640 640 640 320
A/swine/Ohio/10SW206/2010 Beta 80 10 640 640 640 640 640 320
A/swine/Ohio/10SW207/2010 Beta 160 20 2,560 1,280 2,560 640 1,280 1,280
A/swine/Ohio/10SW208/2010 Beta 80 10 640 1,280 1,280 640 640 640
A/swine/Ohio/10SW209/2010 Beta 80 10 1,280 1,280 1,280 640 1,280 1,280
A/swine/Ohio/10SW210/2010 Beta 160 10 1,280 1,280 1,280 1,280 1,280 640
A/swine/Ohio/10SW211/2010 Beta 40 10 640 640 640 640 640 640
A/swine/Ohio/10SW212/2010 Beta 40 10 640 640 640 640 640 320
A/swine/Ohio/10SW213/2010 Beta 80 10 640 640 1,280 1,280 640 640
A/swine/Ohio/10SW214/2010 Beta 80 10 640 640 1,280 1,280 640 640
A/swine/Ohio/10SW216/2010 Beta 160 20 1,280 1,280 1,280 1,280 1,280 1,280
A/swine/Ohio/10SW218/2010 Beta 80 10 640 640 1,280 640 640 640
A/swine/Ohio/10SW219/2010 Beta 40 10 640 1,280 1,280 1,280 640 640
A/swine/Ohio/10SW220/2010 Beta 80 10 1,280 1,280 1,280 1,280 1,280 640
A/swine/Ohio/11SW119/2011 Beta 40 10 640 640 640 1,280 1,280 640
A/swine/Ohio/11SW177/2011 Beta 80 10 640 640 1,280 1,280 1,280 640
A/swine/Ohio/11SW214/2011 Beta 160 10 2,560 1,280 2,560 2,560 2,560 2,560
A/swine/Ohio/11SW219/2011 Beta 40 10 320 320 320 640 640 320
A/swine/Ohio/11SW344/2011 Beta 10 10 640 640 640 1,280 1,280 640
A/swine/Ohio/11SW349/2011 Beta 80 10 1,280 1,280 1,280 2,560 2,560 1,280
Isolates from commercial swine
A/swine/Nebraska/9330/2006 Alpha 320 160 80 80 80 160 160 10
A/swine/Iowa/11333/2006 Alpha 640 320 40 40 80 320 80 80
A/swine/North Carolina/1026/2007 Alpha 640 320 10 10 80 160 80 10
A/swine/Ohio/9753/2007 Alpha 160 80 10 10 10 10 10 10
A/swine/Missouri/15808/2008 Alpha 160 40 10 10 10 10 10 10
A/swine/Iowa/18469/2008 Alpha 320 160 10 10 10 10 10 10
A/swine/Wisconsin/12627/2009 Alpha 1,280 320 80 20 80 320 80 80
A/swine/North Carolina/23592/2009 Alpha 1,280 320 10 10 10 10 10 10
A/swine/Michigan/33261/2010 Beta 160 20 1,280 1,280 1,280 1,280 1,280 1,280
A/swine/Nebraska/8534/2011 Alpha 40 10 10 10 10 10 10 10
A/swine/Indiana/9622/2011 Beta 40 10 640 1,280 1,280 1,280 1,280 1,280
A/swine/North Carolina/6368/2012 Beta 320 160 640 640 1,280 640 1,280 640
H3N2v isolates from patients
A/Wisconsin/12/2010 Beta 80 20 640 640 640 80 80 320
A/Pennsylvania/14/2010 Beta 320 80 320 320 640 640 640 640
A/Minnesota/11/2010 Beta 20 10 160 640 320 320 320 160
A/Iowa/07/2011 Beta 80 10 320 320 160 640 640 320
a 09SW64, A/swine/Ohio/09SW0964/2009 (H3N2); 09SW96, A/swine/Ohio/09SW96/2009 (H3N2); 10SW130, A/swine/Ohio/10SW130/2010 (H3N2); 10SW156, A/swine/Ohio/
10SW156/2010 (H3N2); 10SW215, A/swine/Ohio/10SW215/2010 (H3N2); 11SW111, A/swine/Ohio/11SW111/2011 (H3N2); 11SW208, A/swine/Ohio/11SW208/2011 (H3N2);
11SW347, A/swine/Ohio/11SW347/2011 (H3N2). All isolates are H3N2 unless specifically stated otherwise.
b Antigenic clusters were defined using the k-means clustering method.
c Values in bold are HI titers with homologous influenza virus isolates that were used to generate ferret antiserum. Each experiment was repeated two times, and each HI value in
this table is an average number from three experiments.
Feng et al.
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TABLE 2 Antigenic characterization of H3N2 swine influenza viruses from Ohio agricultural fairs, 2009 to 2011, using hemagglutination inhibition
assay against ferret antisera for contemporary H3N2 human seasonal influenza viruses
Virusa
Antigenic
groupb
Titer to ferret antiserumc:
BK/1/79 PH/2/82 CE/1/84 MS/1/85 LE/360/86 SI/02/87 SI/60/89 AN/03/93 JO/33/94 NA/933/95 SY/05/97 WI/67/05
09SW64 Alpha 10 10 20 10 10 10 10 20 10 20 10 10
09SW96 Alpha 10 10 10 10 10 10 10 10 10 20 10 10
10SW130 Beta 10 10 160 20 10 10 10 80 10 20 10 10
10SW156 Beta 10 10 160 20 10 15 10 80 10 20 10 10
10SW215 Beta 10 10 80 10 10 30 10 40 10 20 10 10
11SW111 Beta 10 10 10 10 10 20 10 10 10 10 10 10
11SW208 Beta 10 10 80 10 10 10 10 40 10 10 10 10
11SW347 Beta 10 10 80 10 10 10 10 40 10 10 10 10
BK/1/79 2,560 640 640 640 40 10 10 40 10 10 10 10
PH/2/82 640 1,280 1,280 640 160 10 10 160 10 10 10 10
CE/1/84 10 20 1,280 80 20 40 40 10 10 10 10 10
MS/1/85 1,280 1,280 5,120 2,560 640 320 160 320 10 10 10 10
LE/360/86 10 160 640 160 320 40 80 40 10 10 10 10
SI/02/87 10 10 640 20 10 320 160 20 20 10 10 10
SI/60/89 10 10 160 40 20 80 480 40 10 10 10 10
AN/03/93 10 10 20 10 10 10 10 120 20 10 10 10
JO/33/94 10 10 40 10 10 160 10 80 480 40 10 10
NA/933/95 20 20 80 20 20 80 10 40 160 720 160 10
SY/05/97 20 20 20 20 20 10 10 10 10 80 960 10
WI/67/05 10 10 10 10 10 10 10 10 10 10 20 1,280
CIVH3N2 ND ND ND ND ND 27 20 20 20 20 40 20
CIVH3N8 ND ND ND ND ND 20 20 20 20 20 20 20
99AIVH3N2 10 10 10 10 10 10 10 10 10 10 10 10
11AIVH3N2 10 10 10 10 10 10 10 10 10 10 10 10
Isolates from exhibition swine
A/swine/Ohio/09SW63/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW65/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW66/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW69/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW73/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW74/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW77/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW79/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW80/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW81/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW82/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW83/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/09SW84/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/09SW85/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW87/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW88/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW89/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW90/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW91/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/09SW92/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW93/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/09SW94/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/09SW97/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Ohio/09SW98/2009 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Ohio/10SW121/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW122/2010 Beta 10 10 160 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW125/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW127/2010 Beta 10 10 160 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW128/2010 Beta 10 10 320 20 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW131/2010 Beta 10 10 160 20 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW132/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW133/2010 Beta 10 10 160 20 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW134/2010 Beta 10 10 160 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW135/2010 Beta 10 10 320 20 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW136/2010 Beta 10 10 160 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW137/2010 Beta 10 10 160 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW139/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW202/2010 Beta 10 10 160 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW203/2010 Beta 10 10 80 10 10 10 10 40 10 20 10 ND
(Continued on following page)
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Antigenic diversity of H3N2 swine influenza virus isolates
from commercial farms. Three IAV isolates from commercial
swine, A/swine/Michigan/33261/2010 (H3N2), A/swine/Indiana/
9622/2011 (H3N2), and A/swine/North Carolina/6368/2012
(H3N2), were evaluated and groupedwith antigenic clusterH3N2
beta, whereas the nine other IAV isolates from commercial swine
were grouped into the H3N2 alpha cluster (Table 1). Isolation of
an IAV in antigenic cluster alpha [i.e., A/swine/Nebraska/8534/
2011 (H3N2)] and an IAV in antigenic cluster beta [i.e., A/swine/
Indiana/9622/2011 (H3N2)] in the same year implies that multi-
ple antigenic subtypes were cocirculating in commercial swine
populations during the same year.
The HA genes of A/swine/Michigan/33261/2010 (H3N2) and
A/swine/Indiana/9622/2011 (H3N2) in antigenic cluster beta
were phylogenetically close to those of the 2010 and 2011 H3N2
isolates from Ohio agricultural fairs. In contrast, A/swine/North
Carolina/6368/2012 (H3N2) antigenically belongs to antigenic
cluster beta, but the HA gene of this strain was phylogenetically
closer to the HA genes of other isolates in antigenic cluster alpha
than to those HA genes in antigenic cluster beta (Fig. 1A).
Human H3N2v isolates antigenically similar to 2010 and
2011 H3N2 isolates from Ohio agricultural fairs. The four se-
lected human H3N2v isolates were antigenically similar to the
H3N2 isolates from pigs at Ohio agricultural fairs in 2010 and
2011. They were grouped with three IAVs from commercial swine
in antigenic cluster beta (Fig. 2).
TABLE 2 (Continued)
Virusa
Antigenic
groupb
Titer to ferret antiserumc:
BK/1/79 PH/2/82 CE/1/84 MS/1/85 LE/360/86 SI/02/87 SI/60/89 AN/03/93 JO/33/94 NA/933/95 SY/05/97 WI/67/05
A/swine/Ohio/10SW204/2010 Beta 10 10 160 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW205/2010 Beta 10 10 160 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW206/2010 Beta 10 10 80 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW207/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW208/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW209/2010 Beta 10 10 80 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW210/2010 Beta 10 10 80 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW211/2010 Beta 10 10 80 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW212/2010 Beta 10 10 80 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW213/2010 Beta 10 10 80 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW214/2010 Beta 10 10 80 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/10SW216/2010 Beta 10 10 160 10 10 10 10 40 10 10 10 ND
A/swine/Ohio/10SW218/2010 Beta 10 10 160 10 10 10 10 80 10 20 10 ND
A/swine/Ohio/10SW219/2010 Beta 10 10 160 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/10SW220/2010 Beta 10 10 160 10 10 10 10 80 10 40 10 ND
A/swine/Ohio/11SW119/2011 Beta 10 10 160 10 10 10 10 20 10 10 10 ND
A/swine/Ohio/11SW177/2011 Beta 10 10 320 10 10 10 10 40 10 20 10 ND
A/swine/Ohio/11SW214/2011 Beta 10 10 160 10 10 10 10 20 10 10 10 ND
A/swine/Ohio/11SW219/2011 Beta 10 10 80 10 10 10 10 20 10 10 10 ND
A/swine/Ohio/11SW344/2011 Beta 10 10 160 10 10 10 10 20 10 10 10 ND
A/swine/Ohio/11SW349/2011 Beta 10 10 160 10 10 10 10 20 10 10 10 ND
Isolates from commercial swine
A/swine/Nebraska/9330/2006 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Iowa/11333/2006 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/North Carolina/1026/2007 Alpha 10 10 10 10 10 10 10 10 10 40 10 ND
A/swine/Ohio/9753/2007 Alpha 10 10 10 10 10 10 10 10 20 10 10 ND
A/swine/Missouri/15808/2008 Alpha 10 10 80 10 10 10 10 10 20 10 10 ND
A/swine/Iowa/18469/2008 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Wisconsin/12627/2009 Alpha 10 10 10 10 10 10 10 20 10 20 10 ND
A/swine/North Carolina/23592/2009 Alpha 10 10 10 10 10 10 10 10 10 20 10 ND
A/swine/Michigan/33261/2010 Beta 40 10 160 20 10 10 10 10 10 10 10 ND
A/swine/Nebraska/8534/2011 Alpha 10 10 10 10 10 10 10 10 10 10 10 ND
A/swine/Indiana/9622/2011 Beta 10 10 80 10 10 10 10 80 10 40 10 ND
A/swine/North Carolina/6368/2012 Beta 10 10 160 10 10 10 10 10 10 10 10 ND
H3N2v isolates from patients
A/Wisconsin/12/2010 Beta 10 10 165 15 10 10 10 80 10 20 10 10
A/Pennsylvania/14/2010 Beta 10 10 640 10 10 40 10 10 10 10 10 10
A/Minnesota/11/2010 Beta 10 10 240 10 10 20 10 80 10 20 10 10
A/Iowa/07/2011 Beta 10 10 320 10 10 10 10 40 10 10 10 10
a 09SW64, A/swine/Ohio/09SW0964/2009 (H3N2); 09SW96, A/swine/Ohio/09SW96/2009 (H3N2); 10SW130, A/swine/Ohio/10SW130/2010 (H3N2); 10SW156, A/swine/Ohio/
10SW156/2010 (H3N2); 10SW215, A/swine/Ohio/10SW215/2010 (H3N2); 11SW111, A/swine/Ohio/11SW111/2011 (H3N2); 11SW208, A/swine/Ohio/11SW208/2011 (H3N2);
11SW347, A/swine/Ohio/11SW347/2011 (H3N2); BK/1/79, A/Bangkok/1/1979 (H3N2); PH/2/82, A/Philippine/2/82 (H3N2); CE/1/84, A/Caen/1/1984 (H3N2); MS/1/85,
A/Mississippi/1/1985 (H3N2); LE/360/86, A/Leningrad/360/1986 (H3N2); SI/02/87, A/Sichuan/02/1987 (H3N2); SI/60/89, A/Sichuan/60/1989 (H3N2); AN/03/93, A/Ann Arbor/
03/1993 (H3N2); JO/33/94, A/Johannesburg/33/1994 (H3N2); NA/933/95, A/Nanchang/933/1995 (H3N2); SY/05/97, A/Sydney05/1997 (H3N2); WI/67/05, A/Wisconsin/67/2005
(H3N2). All isolates are H3N2 unless specifically stated otherwise.
b Antigenic clusters were defined using the k-means clustering method.
c Values in bold are HI titers with homologous influenza virus isolates that were used to generate ferret antiserum. Each experiment was repeated two times, and each HI value in
this table is an average number from three experiments.
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H3N2 swine influenza viruses antigenically similar tohistor-
ical human seasonal influenza viruses. The H3N2v isolates and
H3N2 IAV isolates from pigs at fairs and commercial swine farms
reacted with a limited number of ferret antisera produced against
seasonal influenza viruses from 1982 to 1995, including A/Philip-
pines/2/82 (H3N2), A/Caen/1/1984 (H3N2), A/Mississippi/1/
1985 (H3N2), A/Leningrad/360/1986 (H3N2), A/Sichuan/02/1987
(H3N2), A/Sichuan/60/1989 (H3N2), A/Ann Arbor/03/1993
(H3N2), A/Johannesburg/33/1994 (H3N2), and A/Nanchang/933/
1995 (H3N2) (Table 2). The viruses demonstrated different pat-
terns of cross-reactivity with these ferret antisera but lacked a tem-
poral pattern, which was evident among the human seasonal
influenza viruses, reflecting continuous antigenic drifts. The ferret
antisera against A/Caen/1/1984 (H3N2), A/Ann Arbor/03/1993
(H3N2), andA/Nanchang/933/1995 (H3N2) had relatively higher
HI titers against theH3N2v andH3N2 swine-origin IAVs than did
those against other seasonal IAVs. The ferret antiserum against
A/Caen/1/1984 (H3N2) had the highest degree of cross-reactivity
with the IAVs in antigenic cluster beta and showed an HI titer up
to 1:640. In general, the IAV isolates in antigenic cluster beta,
including the fourH3N2v isolates, three isolates from commercial
swine, and isolates frompigs at the 2010 and 2011 fairs, had higher
degrees of cross-reactivity with these historical human seasonal
influenza viruses than did those in antigenic cluster alpha, as de-
termined by HI titers (Table 2).
TABLE 3 Antigenic characterization of H3N2 swine influenza viruses from Ohio agricultural fairs, 2009 to 2011, using hemagglutination inhibition
assay against ferret antisera for contemporary H3 subtypes of canine and avian influenza viruses
Virusa
Titer to ferret antiserumb:
Canine influenza virus Avian influenza virus
CIVH3N2 CIVH3N8 99AIVH3N2 11AIVH3N2
09SW64 10 10 10 10
09SW96 10 10 10 10
10SW130 10 10 10 10
10SW156 10 10 10 10
10SW215 10 10 10 10
11SW111 10 10 10 10
11SW208 10 10 10 10
11SW347 10 10 10 10
CIVH3N2 1,280 40 320 160
CIVH3N8 40 160 10 10
99AIVH3N2 ND 10 70 20
11AIVH3N2 ND 80 20 320
Isolates from commercial swine
A/swine/Nebraska/9330/2006 10 10 10 10
A/swine/Iowa/11333/2006 10 10 10 10
A/swine/North Carolina/1026/2007 10 10 10 10
A/swine/Ohio/9753/2007 10 10 10 10
A/swine/Missouri/15808/2008 10 10 10 10
A/swine/Iowa/18469/2008 10 10 10 10
A/swine/Wisconsin/12627/2009 10 10 10 10
A/swine/North Carolina/23592/2009 10 10 10 10
A/swine/Michigan/33261/2010 10 10 10 10
A/swine/Nebraska/8534/2011 10 10 10 10
A/swine/Indiana/9622/2011 10 10 10 10
A/swine/North Carolina/6368/2012 10 10 10 10
H3N2v isolates from patients
A/Wisconsin/12/2010 10 10 10 10
A/Pennsylvania/14/2010 10 10 10 10
A/Minnesota/11/2010 10 10 10 10
A/Iowa/07/2011 10 10 10 10
a See the notes for Table 1. CIVH3N2, A/canine/Guangdong/1/2006 (H3N2); CIVH3N8, A/canine/Iowa/13628/2005 (H3N8); 99AIVH3N2, A/blue-winged teal/Ohio/99-31/99
(H3N2); 11AIVH3N2, A/blue-winged teal/Ohio/11OS2474/2011 (H3N2). All isolates are H3N2 unless specifically stated otherwise.
b Values in bold are HI titers with homologous influenza virus isolates that were used to generate ferret antiserum. Each experiment was repeated two times, and each HI value in
this table is an average number from three experiments. ND, not determined.
TABLE 4 Summary of swine influenza virus isolates from Ohio
agricultural fairs used for generating ferret antisera
Isolate Agricultural fair
A/swine/Ohio/09SW64/2009 (H3N2) B
A/swine/Ohio/09SW96/2009 (H3N2) C
A/swine/Ohio/10SW130/2010 (H3N2) C
A/swine/Ohio/10SW156/2010 (H3N2) D
A/swine/Ohio/10SW215/2010 (H3N2) E
A/swine/Ohio/11SW111/2011 (H3N2) H
A/swine/Ohio/111SW208/2011 (H3N2) C
A/swine/Ohio/11SW347/2011 (H3N2) F
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Antigenic analyses also showed that no isolates tested in the
study reacted with antisera raised against one canine-origin [A/
canine/Guangdong/1/2006 (H3N2)], one equine-origin [A/ca-
nine/Iowa/13628/2005 (H3N8)], and two wild-bird-origin [A/
blue-winged teal/Ohio/99-31/99 (H3N2) andA/blue-winged teal/
Ohio/11OS2474/2011 (H3N2)] IAVs (Table 3).
Confirmation of HI-based antigenic profiling using MN as-
say. To validate the antigenic profiling generated by HI tests, we
performed MN assays for one seasonal influenza virus [A/Ann
Arbor/03/1993 (H3N2)], three swine influenza virus isolates from
agricultural fairs, and 12 swine influenza virus isolates from com-
mercial farms against five ferret antisera (Table 6). The results
fromMN assays are consistent with those fromHI tests (Table 1).
The MN titers for one isolate against a serum generated using a
reference isolate in the same antigenic cluster are at least 2-fold
higher than those for this isolate against a serum generated using a
reference isolate from a different antigenic cluster. For example,
A/swine/Ohio/11SW347/2011 (H3N2) hasMN titers of 80 against
the ferret sera against A/swine/Ohio/10SW215/2010 (H3N2) and
A/swine/Ohio/11SW347/2011 (H3N2) whereas A/swine/Ohio/
11SW347/2011 (H3N2) does not cross-react with the ferret sera
for A/swine/Ohio/09SW64/2009 (H3N2) (Table 6).
Molecular characterization of the HA segment of the IAV
isolates. There are 18 amino acid differences between the HA
segments of the 2009 and 2010/2011 isolates from Ohio agricul-
tural fairs, including residue 50 in the antibody binding site (C),
57(E), 107, 117(D), 131(A), 133(A), 139, 142(A), 155(B), 158(B),
163(B), 164(B), 189(B), 203(D), 273(C), 275(C), 276(C), and 289
(Table 7). The reported antibody binding sites were annotated
based on previous studies (42). However, when the isolates from
FIG1 Phylogenetic analysis ofHA (A) andNA (B) gene segments ofH3N2 IAV isolates frompigs atOhio agricultural fairs (2009 to 2011) TheH3N2 IAV isolates
from exhibition swine fromOhio agricultural fairs aremarked in red, and humanH3N2 variant (H3N2v) influenza virus isolates are underlined. TheH3N2 IAV
isolates from commercial swine included in this study are marked in purple, and the representative strains of H3N2 antigenic clusters are marked in cyan. The
phylogenetic analyses were performed using maximum likelihood by the GARLI version (39), and bootstrap resampling analyses were performed using PAUP*
4.0 Beta (40) to apply a neighborhood joining method, as described earlier (41).
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commercial swine were included in analyses, most of the residues
in those positions varied across different strains and only the one
at 189(B) had a consistent mutation (R189K) between the viruses
in antigenic cluster alpha and the viruses in antigenic cluster beta.
The lysine (K) residue at position 189 was present in the A/swine/
North Carolina/6368/2012 isolate that was phylogenetically closer
to H3N2 isolates located in antigenic cluster alpha (Fig. 1A). In
comparison, the representative H3N2 strains A/swine/Texas/
4199-2/1998 (cluster I), A/swine/Colorado/23619/1999 (cluster
II), and A/swine/Oklahoma/18089/1999 (cluster III) had a serine
(S) at position 189 whereas A/swine/Ontario/33853/2005 (cluster
IV) had an arginine (R) in the same position. The human H3N2
TABLE 5 Sequence identity of HA genes in H3N2 swine influenza virus isolates from Ohio agricultural fairs (2009 to 2011) in comparison to
human-origin H3N2 isolates
Viral isolate Abbreviation
Nucleotide/protein sequence identity (%)
ON33853 09SW64 09SW96 10SW130 10SW156 10SW215 11SW111 11SW208 11SW226 11SW347 IA07
A/swine/Ontario/33853/2005 ON33853 100/100 98.1/98.4 98.0/98.2 97.5/96.8 97.6/97.0 97.6/97.0 96.9/96.5 96.9/96.5 96.9/96.5 96.9/96.5 97.2/97.0
A/swine/09SW64/2009 09SW64 100/100 99.9/99.8 96.2/95.8 96.1/95.6 96.1/95.6 95.5/95.1 95.4/95.1 95.1/95.1 95.4/95.1 95.8/95.6
A/swine/09SW96/2009 09SW96 100/100 96.1/95.6 96.1/95.4 96.1/95.4 95.5/94.9 95.4/94.9 95.4/94.9 95.4/94.9 95.8/95.4
A/swine/10SW130/2010 10SW130 100/100 99.9/99.8 99.9/99.8 99.2/99.3 99.2/99.3 99.2/99.3 99.2/99.3 99.5/99.8
A/swine/10SW156/2010 10SW156 100/100 100/100 99.3/99.5 99.3/99.5 99.3/99.5 99.3/99.5 99.6/100
A/swine/10SW215/2010 10SW215 100/100 99.3/99.5 99.3/99.5 99.3/99.5 99.3/99.5 99.6/100
A/swine/11SW111/2011 11SW111 100/100 99.9/100 99.9/100 99.9/100 99.2/99.5
A/swine/11SW208/2011 11SW208 100/100 100/100 100/100 99.2/99.5
A/swine/11SW226/2011 11SW226 100/100 100/100 99.2/99.5
A/swine/11SW347/2011 11SW347 100/100 99.2/99.5
A/Iowa/07/2011 IA07 100/100
FIG 2 Antigenic cartography for H3N2 swine influenza virus isolates from Ohio agricultural fairs (2009 to 2011) and human H3N2v influenza virus isolates.
Four human H3N2v isolates and 12 swine influenza viruses from commercial farms were specifically labeled. Antigenic cartography was constructed using
AntigenMap (http://sysbio.cvm.msstate.edu/AntigenMap) based on HI data from Table 1 (32, 33).
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isolates A/Ann Arbor/3/1993 and A/Nanchang/933/1995 pos-
sessed S at position 189, whereas A/Caen/1/1984 hadK in the same
position, 189K, which could explain the strong cross-reactivity
betweenA/Caen/1/1984 and theH3N2 isolates in antigenic cluster
beta.
DISCUSSION
Livestock exhibitions at agricultural fairs continue to be popular
and an important educational extension of modern agriculture
(43). Sporadic human infections with swine-origin IAVs have
been reported in conjunction with agricultural fairs over several
years (1–3). Currently, agricultural fairs are considered important
sites of bidirectional interspecies transmission of IAVs, evidenced
by more than 300 H3N2v infections occurring in 14 states during
2011 and 2012 (44). A majority of the human cases reported hav-
ing direct or indirect exposure to swine at agricultural fairs (7).
Thus, it is critical to develop intervention strategies aimed at mit-
igating the risk of zoonotic IAV transmission at fairs by reducing
the amount of IAV in the fair environment. Development of an
effective vaccination strategy for exhibition swine might accom-
plish this goal by decreasing the number of susceptible pigs at fairs
and by shortening the duration of viral shedding for IAV-infected
pigs. It is also important to understand the degree of immunity
that fair attendees may or may not have to IAVs circulating at the
swine-human interface. Therefore, it is important and necessary
to characterize the antigenic profiles of the IAVs common among
exhibition swine at agricultural fairs.
With antigenic cartography, we have demonstrated that 68
H3N2 IAV isolates from pigs at Ohio fairs during 2009 to 2011
could be divided into two antigenic groups: (i) the 2009 and (ii)
the 2010 and 2011 fair isolates (Fig. 2). Furthermore, our results
demonstrated that antigenic dynamics observed among theH3N2
IAV isolates from Ohio exhibition swine were generally similar
across the fairs sampled in the same year but could be significantly
different from year to year, e.g., the H3N2 isolates in 2009 were
antigenically distant from those in 2010 and 2011. The antigenic
profiles of H3N2 isolates from 2010-2011 fairs were similar to
those of 2010 and 2011 human H3N2v isolates, further establish-
ing the role of exhibition swine in the emergence of H3N2v infec-
tions among humans.
In this study, 12 H3N2 isolates from commercially raised pigs
were also included in analyses. Albeit theywere limited in number,
antigenic characterization of these IAVs from commercial swine
demonstrated that there were variations in antigenic profiles, sug-
gesting that there are at least two antigenic clusters of H3N2 IAVs,
H3N2 alpha andH3N2beta, circulating among commercial swine
in theUnited States. Three of the 12 IAV isolates from commercial
swine were antigenically similar to those isolates forming cluster
H3N2 beta, which included the H3N2 IAV isolates from 2010 and
2011 fairs and four human H3N2v isolates. This finding suggests
that the H3N2 IAVs infecting pigs, and subsequently humans, at
fairs are linked to the IAVs circulating in commercial swine herds
despite the fact that exhibition swine are generally considered to
be a population separate from commercial swine and are raised in
different settings (45). The observed antigenic complexity of IAVs
in commercial swine populations might be linked to the variable
application of commercial and autogenous IAV vaccines in the
U.S. swine industry. A large scale of antigenic characterization of
H3N2 IAVs infecting pigs will be required to fully characterize the
antigenic diversities and evolution of the H3N2 IAVs in swine
populations.
One previous study suggested that the protein sequence iden-
tity could be used to differentiate antigenic clusters of H3N2 IAVs
infecting swine (22). However, our results indicated that the rate
of antigenic evolution among H3N2 swine-origin IAVs could be
independent of the rate of genetic evolution and that the protein
sequence similarity alone does not predict IAV antigenic relation-
ships. For example, the HA amino acid sequence of A/swine/
North Carolina/6368/2012 (H3N2) is 95% identical to that of
A/Iowa/7/2011 (H3N2), 94.5% identical to that of A/swine/Ohio/
11SW111/2011 (H3N2), and 95.9% identical to that of A/swine/
Ohio/09SW64/2009 (H3N2). A/swine/North Carolina/6368/2012
TABLE 6 Antigenic characterization of H3N2 swine influenza viruses from Ohio agricultural fairs, 2009 to 2011, using microneutralization assay
Virusa Antigenic groupb
Titer to ferret antiserumc:
09SW64 10SW215 11SW347 CE/1/84 AN/03/93
A/swine/Ohio/09SW64/2009 Alpha 1,280 40 40 10 20
A/swine/Ohio/10SW215/2010 Beta 80 640 160 80 40
A/swine/Ohio/11SW347/2011 Beta 10 80 80 40 10
A/Ann Arbor/03/1993 10 10 10 10 40
A/swine/Nebraska/9330/2006 Alpha 160 10 10 10 10
A/swine/Iowa/11333/2006 Alpha 1,280 80 80 10 10
A/swine/North Carolina/1026/2007 Alpha 1,280 80 20 10 20
A/swine/Ohio/9753/2007 Alpha 160 10 20 10 10
A/swine/Missouri/15808/2008 Alpha 40 10 10 160 10
A/swine/Iowa/18469/2008 Alpha 320 10 20 10 10
A/swine/Wisconsin/12627/2009 Alpha 640 80 80 10 10
A/swine/North Carolina/23592/2009 Alpha 1,280 10 10 10 10
A/swine/Michigan/33261/2010 Beta 20 320 320 20 10
A/swine/Nebraska/8534/2011 Alpha 10 10 10 20 10
A/swine/Indiana/9622/2011 Beta 20 160 320 40 40
A/swine/North Carolina/6368/2012 Beta 320 640 640 320 10
a 09SW64, A/swine/Ohio/09SW0964/2009 (H3N2); 10SW215, A/swine/Ohio/10SW215/2010 (H3N2); 11SW347, A/swine/Ohio/11SW347/2011 (H3N2); CE/1/84, A/Caen/1/1984
(H3N2); AN/03/93, A/Ann Arbor/03/1993. All isolates are H3N2 unless specifically stated otherwise.
b Antigenic clusters were defined using the k-means clustering method.
c Values in bold are microneutralization titers with homologous influenza virus isolates that were used to generate ferret antiserum.
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(H3N2) was genetically closer to IAVs in H3 cluster IV than to the
2010/2011 fair isolates that were also classified into cluster IV.
HI-based antigenic cartography showed that A/swine/North Car-
olina/6368/2012 (H3N2) was antigenically closer to 2010/2011
fair isolates and H3N2v isolates [e.g., A/swine/Ohio/11SW111/
2011 (H3N2) and A/Iowa/7/2011 (H3N2)] than to the other
swine-origin IAV isolates [e.g., A/swine/Ohio/09SW64/2009
(H3N2)] (Fig. 2). Molecular characterization of the selected
H3N2 viruses in our study suggests that the amino acid residue at
189, which is part of epitope B, could be important in determining
antigenic profiles (Table 7), and further experiments are required
to confirm these results. This observation is similar to that in
human H3N2 seasonal influenza viruses, in which only one or a
few of these residues change during antigenic drift (46–50).
Antigenic characterization performed in this study was based
on ferret sera, which have been used as the gold standard in anti-
genic variant detection for seasonal vaccine strain selection and
pandemic preparedness in influenza surveillance (51). The tested
68 H3N2 fair isolates showed different extents of antigenic cross-
reactivity with the ferret antisera produced against selected hu-
man seasonal IAVs from 1982 to 1995 but did not cross-react with
the H3N2 seasonal influenza viruses circulating over the past de-
cade. This result suggests that individuals born before 2000 are
likely to have a different extent of immunity against H3N2v-like
infections because of their exposure to epidemic H3N2 seasonal
influenza viruses before 2000. In contrast, children, especially
thosewhowere born after 2000, likely lack immunity against these
H3N2v-like infections, and this could be a reason that the major-
ity of H3N2v infections occurred in children (7, 44).
Recent ferret experiments showed that human seasonal triva-
lent inactivated influenza vaccine does not protect against H3N2v
(52). Because of the public threat of the emergingH3N2v, it will be
necessary to develop an influenza vaccine against the viruses in
antigenic cluster H3N2 beta, which contains H3N2v isolates and
the 2010 and 2011 Ohio agricultural fair isolates collected from
pigs.
In summary, the current study highlighted the diversity in and
evolutionary complexity of antigenic and genetic properties of
IAVs. The results also demonstrated that H3N2 IAVs infecting
swine at agricultural fairs in Ohio during 2009 to 2011 were anti-
genically different from recent seasonal H3N2 IAVs circulating in
humans. This raises the question of the level of immunity in the
human population to these IAVs. Therefore, continued surveil-
lance and subsequent antigenic characterization of IAVs present
at the swine-human interface are needed.
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